sintilimab: Clinical Trials

4 trials of sintilimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 1 enrolling by invitation. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Not yet recruiting 3, Enrolling by invitation 1

Follow sintilimab: new trials by email Literature Review of sintilimab trials Research Report on sintilimab

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study
Dabrafenib, Trametinib, Selpercatinib - Thyroid Neoplasms
Phase 4Not yet recruitingFujian Medical University3352025-07-012025-06-08
Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer
Sintilimab plus Chemotherapy, Intestinal microbiota capsules, Standard Long Course Radiotherapy - Localized Advanced Rectal Adenocarcinoma
Phase 4Enrolling by invitationFirst Affiliated Hospital of Ningbo University202025-03-012025-04-17
BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma
Brentuximab Vedotin (Bv), Sintilimab, Tislelizumab - Hodgkin Lymphoma (Category)
Phase 4Not yet recruitingXiuhua Sun1002024-12-312025-01-07
Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
Irinotecan Hydrochloride Liposome Injection - Gastric Cancer
Phase 4Not yet recruitingFirst Affiliated Hospital Xi'an Jiaotong University442024-07-152024-07-12

Conditions studied

Hodgkin Disease (1)  ·  Recurrence (1)  ·  Stomach Neoplasms (1)  ·  Thyroid Neoplasms (1)

Sponsors

First Affiliated Hospital Xi'an Jiaotong University (1)  ·  First Affiliated Hospital of Ningbo University (1)  ·  Fujian Medical University (1)  ·  Xiuhua Sun (1)

Countries

China (3)

Top investigators

Enxiao Li, doctor (1)